Arana A, Cuchi T, Arellano F. Strengthening EU pharmacovigilance. European pharmaceutical contractor. European pharmaceutical contracto: EPC. 2009;44-5.
Hoogeveen EK, Rothman KJ. Hyperhomocysteinemia increases the risk of death in type 2 diabetes. Cardiovasc Rev Rep. 2001;22:207-12.